Does pharmacomechanical catheter-directed thrombolysis reduce the risk of post-thrombotic syndrome in patients with proximal deep-vein thrombosis?
Pharmacomechanical catheter-directed thrombolysis is hypothesized to reduce the risk of post-thrombotic syndrome in patients with proximal deep-vein thrombosis.
The post-thrombotic syndrome frequently develops in patients with proximal deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical catheterdirected thrombolysis (hereafter "pharmacomechanical thrombolysis") rapidly removes thrombus and is hypothesized to reduce the risk of the post-thrombotic syndrome.
Vedantham et al. (Wed,) studied this question.